Your Health, We Care
The most common (≥ 20%) adverse reactions are:
1.As a single agent: diarrhea, fatigue, PPE, decreased appetite, hypertension, nausea, vomiting, weight decreased, constipation.
2.In combination with nivolumab: diarrhea, fatigue, hepatotoxicity, PPE, stomatitis, rash, hypertension, hypothyroidism, musculoskeletal pain, decreased appetite, nausea, dysgeusia, abdominal pain, cough, and upper respiratory tract infection.
from FDA，2023.09
After administration, necessary therapeutic effects may occur, and adverse reactions may also be tri···【more】
Recommended：562026-05-02
Cabozantinib is a small-molecule multi-targeted tyrosine kinase inhibitor developed by Exelixis, Inc. (USA). It was first approved by the FDA in November 2012 for progressive metas···【more】
Article source：Lucius LaosRelease date：2026-03-20Recommended：45
Cabozantinib is a broad‑spectrum multi‑targeted anticancer drug that inhibits at least 9 targets, including MET, VEGFR1/2/3, ROS1, RET, AXL, NTRK, and KIT.Side Effects Requiring Im···【more】
Article source：Lucius LaosRelease date：2026-03-20Recommended：36
After administration, necessary therapeutic effects may occur, and adverse reactions may also be triggered. Not all adverse reactions will manifest. If any adverse reaction occurs,···【more】
Article source：Lucius LaosRelease date：2026-02-05Recommended：56
Cabozantinib is a widely used drug for the treatment of a variety of cancers, and its side effects are of great concern.Does cabozantinib have side effectsExploring the side effect···【more】
Article source：Lucius LaosRelease date：2025-02-21Recommended：214
Cabozantinib is a multi-targeted tyrosine kinase inhibitor that has demonstrated significant efficacy in a variety of cancer treatments. However, its accompanying side effects have···【more】
Article source：Lucius LaosRelease date：2025-02-21Recommended：256
Cabozantinib is a multi-targeted tyrosine kinase inhibitor that has shown significant efficacy in the treatment of a variety of cancers, but its accompanying side effects are also ···【more】
Article source：Lucius LaosRelease date：2025-02-20Recommended：253
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
